GQR’s Post

Exciting news from Q-lineaAB! With the first two ASTar systems now installed in the US, pending market approval, we're gearing up for a significant milestone. CEO Jonas Jarvius highlights this step as part of the imminent commercial launch, positioning us to serve potential customers better. Jim Kathrein, VP of Commercial Operations, expresses enthusiasm for the impact of rapid AST in healthcare. 📰 Follow Practical Patient Care to receive the latest healthcare news daily that is important to you and to subscribe to our weekly newsletter #practicalpatientcare #QlineaAB #ASTar #HealthcareInnovation

Looking at #tender data over the last 10 years in #Europe reveals an interesting trend: It shows an increase in bids that are awarded without being published first.   This is not only bad for #competition in general, but can directly lead to lost revenues for all the companies not included into the #bidding process. Worrying to see such an increase in #Healthcare over the last 3 years (2019 - 2021)   Stay tuned for another trend about single / non-competitive bidding… Cube RM #tender #pharma #medtech

Reminder: Details of the reporting requirements are outlined in our MedPharma Transparency Newsletter.  To learn more, contact us at: compliance@vectorhealth.net #VectorHealthCompliance #MedPharmaTransparency #GlobalTransparencyReporting

Will Akili's shift to OTC bring DTx to the masses? As Akili seek FDA approval for their move to an over-the-counter business model, will wider availability mean wider adoption of their DTx? Read the full article here and let us know your thoughts in the comments ➡️ https://lnkd.in/eD3ETeKp  #DTx #FDA #digitalhealth

Exciting Announcement! #RxParadigm is elated to announce our participation at the #2023MDRPSummit in Chicago, IL! Our very own CEO, Mesfin Tegenu, will be moderating an intriguing panel covering one of the most challenging topics in the pharmacy industry titled "Policy and Transparency Developments in #340B". Joining the discussion will be the esteemed Maureen Testoni, President and CEO of #340BHealth, and Cathy Burton-Meza, Associate Director, Government #Rebates at #GileadSciences. Topics to be covered include: 1. The evolution and growth of the 340B program and the varying interests from different stakeholders for legislative change. 2. Delving deep into the workload tied to data sharing and the related privacy/transparency concerns. 3. The significance of the 340B #Clearinghouse in streamlining data validation across all stakeholders. 4. Evaluating the pros and cons of transitioning the 340B discount administration from a direct purchase to a rebate option. Mark your calendars! You will not want to miss this insightful discussion on September 19th, from 3:00 pm to 3:40 pm. We invite all attendees to be a part of this pivotal conversation, gain insights, and engage with industry leaders. See you there! #MDRPSummit2023 #340B #PharmacyPolicy #Transparency #RxParadigm

What it means to be disruptive and how that can be beneficial to a given industry

Luke S. & Katie Litwin discuss how GQR is disrupting the industry and what it really means when we say that our experts are your experts. Learn more about our Life Sciences team and how we can partner with you and your organization today ➡️ https://lnkd.in/gYzFcsQv #GQRlifesciences #GQRsolutions #GQR #lifeatGQR

Journal "Med-Tech Dialogue" (MTD 01/2024) reporting on my webinar hosted by BVMed - Bundesverband Medizintechnologie on revised EU-MDR transition periods and Blue Guide "placing on the market". Despite relaxed deadlines, manufacturers may still face challenges.  #medicaldevices #MDR #placingonthemarket #transitionperiods

Please take a moment to listen to Mary speak about a very important topic #GLP1s have become the #drugclass of choice in the weight loss category. In this MedTalks Minute, hear MedImpact Healthcare Systems, Inc.'s VP of #Clinical Services discuss the current landscape of these popular drugs. Stay tuned for Part Two to hear what #payers need to know! #wearemedimpact #atruepartner #weightmanagement #drugtrends #medtalksminute

A new chapter in our professional life begins today. New colleagues, new opportunities, new geographies, but same enthusiasm, commitment, passion and love for this work. #TeamIntexo #MarketAccess #ScientificRegulatory #TogetherStronger Intexo Società Benefit ProductLife Group